117 related articles for article (PubMed ID: 33405856)
1. Folic-Acid-Adorned PEGylated Graphene Oxide Interferes with the Cell Migration of Triple Negative Breast Cancer Cell Line, MDAMB-231 by Targeting miR-21/PTEN Axis through NFκB.
Basu A; Upadhyay P; Ghosh A; Chattopadhyay D; Adhikary A
ACS Biomater Sci Eng; 2019 Jan; 5(1):373-389. PubMed ID: 33405856
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
3. Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
Ahir M; Bhattacharya S; Karmakar S; Mukhopadhyay A; Mukherjee S; Ghosh S; Chattopadhyay S; Patra P; Adhikary A
Biomaterials; 2016 Jan; 76():115-32. PubMed ID: 26520043
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Nur Azlina MF; Arulselvan P
Int J Nanomedicine; 2024; 19():1109-1124. PubMed ID: 38344441
[TBL] [Abstract][Full Text] [Related]
6. miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN.
Fang H; Xie J; Zhang M; Zhao Z; Wan Y; Yao Y
Am J Transl Res; 2017; 9(3):953-961. PubMed ID: 28386324
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer.
Li Q; Liu J; Meng X; Pang R; Li J
J Biol Res (Thessalon); 2017 Dec; 24():10. PubMed ID: 28795052
[TBL] [Abstract][Full Text] [Related]
8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
10. Graphene Oxide Nanoparticle-Loaded Ginsenoside Rg3 Improves Photodynamic Therapy in Inhibiting Malignant Progression and Stemness of Osteosarcoma.
Lu SL; Wang YH; Liu GF; Wang L; Li Y; Guo ZY; Cheng C
Front Mol Biosci; 2021; 8():663089. PubMed ID: 33968991
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
12. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
14. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
[TBL] [Abstract][Full Text] [Related]
16. Silymarin-Loaded, Lactobionic Acid-Conjugated Porous PLGA Nanoparticles Induce Apoptosis in Liver Cancer Cells.
Upadhyay P; Bhattacharjee M; Bhattacharya S; Ahir M; Adhikary A; Patra P
ACS Appl Bio Mater; 2020 Oct; 3(10):7178-7192. PubMed ID: 35019376
[TBL] [Abstract][Full Text] [Related]
17. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Abadpour A; Moumivand E; Mojarrad JS; Rashidi MR; Coukos G; Omidi Y
Colloids Surf B Biointerfaces; 2013 Jun; 106():117-25. PubMed ID: 23434700
[TBL] [Abstract][Full Text] [Related]
19. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
20. Active Hydrophilic Graphene Oxide Nanocomposites Delivery Mediated by Adipose-Derived Stem Cell for Elevated Photothermal Therapy of Breast Cancer.
Peng Z; Chang Q; Xing M; Lu F
Int J Nanomedicine; 2023; 18():971-986. PubMed ID: 36855539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]